For the third quarter of FY2026 (ending December 2026), consolidated results were revenue 3,063,829 thousand yen, operating income 205,932 thousand yen, profit before tax 201,291 thousand yen, and profit for the quarter attributable to owners of the parent 114,543 thousand yen. Revenue from discontinued operations was limited. Full-year forecast remains unchanged. The company is promoting business restructuring centered on physician value-creation services. Overseas expansion is being strengthened, focusing on the ASEAN region.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"price_fetched_at":"","company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"6034","jir_company_name":"MRT Inc.","jir_importance":"\u2605\u2605\u2605\u2605\u2606","jir_publication_date":"2026-11-13","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/11\/6034-20261113-02.pdf","jir_short_summary":"For the third quarter of FY2026 (ending December 2026), consolidated results were revenue 3,063,829 thousand yen, operating income 205,932 thousand yen, profit before tax 201,291 thousand yen, and profit for the quarter attributable to owners of the parent 114,543 thousand yen. Revenue from discontinued operations was limited. Full-year forecast remains unchanged. The company is promoting business restructuring centered on physician value-creation services. Overseas expansion is being strengthened, focusing on the ASEAN region.","jir_summary":"### Overview of Results\nMRT Inc., which operates digital and talent platform businesses in the medical and healthcare sectors, reported consolidated revenue from continuing operations of 3,063,829 thousand yen, operating income of 205,932 thousand yen, profit before tax of 201,291 thousand yen, and profit for the quarter attributable to owners of the parent of 114,543 thousand yen for the third quarter of FY2026 (ending December 2026). The transfer of shares in the formerly discontinued business \"Doctors Creating Together\" has been completed, and revenue composition is led by physician value-creation services. Under the medium-term plan, the company is also focusing on new businesses that return physicians' expertise to society. Overseas expansion is being expanded mainly in the ASEAN region.\n\n### Business Strategy and Financial Outlook\nUnder the medium-term management plan, the company is strengthening physician career support and medical DX areas. It is advancing business integration and organizational restructuring domestically and internationally to capture opportunities in growth areas and improve matching accuracy. The financial position shows total assets of 6,238,492 thousand yen (decrease from the previous fiscal year-end), equity of 4,714,559 thousand yen, and the composition of shareholders' equity has been adjusted through the acquisition of treasury stock. There is no change to the full-year earnings forecast, and no revisions have been disclosed at this time.","jir_financial_highlights":"Revenue: 3,063,829 thousand yen (Year-over-Year (YoY) increase of 3.3%)\nOperating Income: 205,932 thousand yen (Year-over-Year (YoY) increase of 70.9%)\nProfit Before Tax: 201,291 thousand yen (Year-over-Year (YoY) increase of 62.3%)\nProfit for the Quarter Attributable to Owners of the Parent: 114,543 thousand yen (Year-over-Year (YoY) increase of 50.2%)\nTotal Assets: 6,238,492 thousand yen (Decrease compared with the end of the previous consolidated fiscal year)\nTreasury Stock: -168,933 thousand yen (Increase compared with the end of the previous fiscal year)","jir_category":"","jir_hashtags":"#MRTInc, #Earnings, #MediumTermManagementPlan, #PhysicianValueCreationServices","jir_key_figures":"Revenue: 3,063,829 thousand yen (YoY increase of 3.3%)\nOperating Income: 205,932 thousand yen (YoY increase of 70.9%)\nProfit for the Quarter Attributable to Owners of the Parent: 114,543 thousand yen (YoY increase of 50.2%)","jir_meta_title":"MRT Inc. Third Quarter Financial Summary | FY2026","jir_meta_description":"Summary of MRT Inc.'s FY2026 third quarter results: revenue 3,063 million yen, operating income 206 million yen, restructuring of discontinued operations, expansion of medical DX and overseas activities centered on ASEAN, and unchanged full-year forecast.","jir_og_title":"Key Points of MRT Inc. Third Quarter Results","jir_og_description":"MRT Inc.'s third quarter results: revenue 3,063 million yen, operating income 205 million yen. The company is streamlining discontinued operations and strengthening medical DX and overseas expansion.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":60509,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"financial_summary","footnotes":""},"sector":[],"importance":[],"class_list":["post-153101","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n